Login

BWRX300: Promising SMR by GE Hitachi | GE Hitachi - Vice President of Small Modular Reactors 00:10:00

Share On Facebook Share On Twitter

GE Hitachi is the Vice President of Small Modular Reactors

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
A Lifelong Journey of Service: Defending the U.S. Constitution|Lt. Col. Tom Kulisz
00:10:00
Ole Kristian Sivertsen Explores Solutions for Water Scarcity and Desertification in U.S. Farming | Ole Kristian Sivertsen, CEO, Desert Control AS.
00:10:00
Harnessing Industry 8.0 for Renewable Efficiency and Predictive Maintenance| Luca Bettonte, CEO,ERG SPA.
00:10:00
CEO Luiz Osório Dumoncel on the Company's Growth and Unique Position in Agribusiness | Luiz Osório Dumoncel, CEO, Três Tentos Agroindustrial SA.
00:10:00
disrupt existing markets or create entirely new ones|Matt Harris,Partner,Bain Capital Ventures
00:10:00
MBI Global Formed: Alliance of Leading Drilling and Mining Equipment Companies
00:10:00
Weston Goldmines' Growth and Innovations: From Exploration Success to Strategic Partnerships.
00:10:00
GoldSource Mines: Advancing the High-Return Eagle Mountain Gold Project in Guyana
00:10:00
The technology improves over many years it could replace text entirely|Josh Coyne,Partner,Kleiner Perkins
00:10:00
Standing Out to Clients: Insights from Morgan Stanley's CMO and Facebook's VP of Global Marketing Solutions
00:00:00
Investigate why photoreceptor cells die / Constance Cepko, Ph.D. HARVARD MEDICAL SCHOOL
00:10:00
Ciena CEO Gary Smith delivers a keynote at PTC'18 on embracing change and disruption as industry standards and transformative agents.

© 2017 - Neuhu+